Pioglitazone 15 mg Tablet (Pioglitazone Hydrochloride)

Adult dose

This medication is taken orally once a day, regardless of meals. For monotherapy, it begins at 15 mg daily and may be increased to 30 mg daily if the effect is insufficient. For combination therapy, it is administered at 15 mg once daily with sulfonylureas, metformin, or insulin. The maximum recommended dose does not exceed 30 mg once daily.

Child dose

Use in pediatric patients under 18 years has not been established, and administration is not recommended.

This medication is used to treat type 2 diabetes and works with insulin to control blood sugar levels. This medication may put stress on the heart and should not be administered to patients with heart failure or a history of heart failure. During treatment, careful observation for symptoms of heart failure such as weight gain, swelling, and shortness of breath is necessary. If symptoms occur, immediate consultation with a physician for appropriate action is required. Patients with active bladder cancer or a history of bladder cancer should also not use this medication. It is contraindicated in patients with severe liver or kidney impairment. Women who are pregnant or may become pregnant should not take this medication, and premenopausal women should use appropriate contraception to prevent pregnancy while taking this medication. This medication carries a risk of hypoglycemia, so it is crucial to be well-informed about hypoglycemic symptoms, especially when taken together with insulin or other hypoglycemic agents, and to respond immediately if they occur. Regular liver function tests and blood sugar tests should be conducted throughout treatment, and if symptoms of liver damage (e.g., fatigue, loss of appetite, jaundice) occur, the physician should be notified immediately. If sudden weight gain or severe swelling occurs during the course of this medication, it should be reported to a doctor. Elderly patients or those with impaired kidney or liver function should use this medication more cautiously and be closely monitored for the possibility of adverse effects. Although special symptoms may not appear in case of overdose, appropriate treatment should be administered based on clinical symptoms. This medication has not been shown to be safe and effective in children, so it is not recommended for use in this age group. While taking this medication, there may be interactions with other medications, so all medications being taken should be reported to a doctor or pharmacist. Lastly, this medication should be kept out of reach of children and stored in its original container to maintain its quality.

Serious side effects

Congestive heart failure, symptoms and signs of heart failure (rapid weight change, difficulty breathing, swelling), bladder cancer, severe heart failure, hospitalization due to hypoglycemia, cardiovascular mortality, liver failure, abnormal liver function tests (elevated ALT, jaundice), severe swelling, severe allergic reactions (hives, severe swelling, chest tightness, difficulty breathing, cold sweat, paleness), serious neurological symptoms (headache, confusion, visual disturbances, paralysis)

Mild side effects

• Upper respiratory infection
• headache
• sinusitis
• muscle pain
• pharyngitis
• abdominal distension
• weight gain
• hypoglycemia
• urinary tract infection
• back pain

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained at room temperature between 1°C and 30°C. Proper storage will help maintain the medication's efficacy and safety for an extended period.

Appearance

White to grayish-white, convex cylindrical tablet

Package unit

30 tablets/bottle